Skip to main content

Month: April 2022

Full Video of Ebix Chairman Robin Raina in a Fireside Chat – on the Topic ‘Aatmanirbhar Bharat – The Global Opportunity’ at Times Network’s India Economic Conclave 2022

MUMBAI, India and JOHNS CREEK, Ga, April 25, 2022 (GLOBE NEWSWIRE) — At the Times Network’s India Economic Conclave in Mumbai on April 22nd 2022, Ebix Chairman Robin Raina said the dream of a self-reliant India cannot be realized without advancing into intellectual property creation as a top national priority. The full video of the 30-minute fireside chat at the India Economic Conclave, with Times Network Executive Editor Mihir Bhatt can be seen on – https://ebixcash.com/allnews/#videos Times Network’s flagship annual event – India Economic Conclave (IEC), was held on Thursday and Friday last week in Mumbai, India at the National Centre for the Performing Arts (NCPA). The two-day event featured many insightful sessions with luminaries such as Former US Secretary of State Mrs. Hilary Clinton, UK Prime Minister Boris Johnson...

Continue reading

With 3.6% CAGR, Cosmetic Surgery Market Size worth USD 58.78 Billion in 2028

Key Prominent Players Covered in the Cosmetic Surgery Market are S.TETIK, Westlake Dermatology, Long Island Plastic Surgical Group, ALLERGAN, Merz Pharma, Galderma Laboratories, Cleveland Clinic and Other Market Players. Pune, India, April 25, 2022 (GLOBE NEWSWIRE) — The global cosmetic surgery market size was USD 44.55 billion in 2020. The market is expected to grow from USD 46.02 billion in 2021 to USD 58.78 billion in 2028, exhibiting a CAGR of 3.6% during the forecast period. Availability of technologically advanced services and products and the rising popularity of new cosmetic procedures may fuel industry growth. Fortune Business Insights™ provides this information in its report titled “Cosmetic Surgery Market, 2021-2028”.  Notable Industry DevelopmentJune 2020: Venus Concept Inc. received an FDA clearance for its Venus...

Continue reading

Science 37 to Report First Quarter 2022 Financial Results on May 9, 2022

RESEARCH TRIANGLE PARK, N.C., April 25, 2022 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it will report first quarter 2022 financial results before the market opens on Monday, May 9, 2022. Company management will host a corresponding conference call at 5:00 a.m. Pacific Time / 8:00 a.m. Eastern Time. Investors interested in listening to the conference call may do so by dialing (844) 467-7754 for domestic callers or (270) 215-9366 for international callers, followed by Conference ID: 1388417. A live and archived webcast of the event will be available on the Investor Relations section of the Science 37 website at https://investors.science37.com/. About Science 37 Science 37 Holdings, Inc.’s (Nasdaq: SNCE) mission is to enable universal access to clinical...

Continue reading

New fixed-rate bonds – Nykredit Realkre

To Nasdaq Copenhagen A/S         New fixed-rate bonds Nykredit opens the following new fixed-rate bonds.3.5% 30-years annuity SDO with interest-only option up to 10 years 3% 20-years annuity SDO 2% 10-years annuity SDOThe new bonds will be used to fund lending in Totalkredit A/S and Nykredit Realkredit A/S. The Final Bond Terms will be published in separate stock exchange announcement. Questions may be addressed to Christian Mauritzen, tel +45 44 55 10 14, or Lars Mossing Madsen, tel +45 44 55 11 66.AttachmentForhåndsmeddelse – UK – 30-årige

Continue reading

With 10.1% CAGR, Blood Glucose Monitoring System Market Size worth USD 31.34 Billion in 2029

According to Fortune Business Insights, the global Blood Glucose Monitoring System Market size is projected to reach USD 31.34 billion in 2029, at CAGR of 10.1% during forecast period; Increasing Prevalence of Diabetes to Bolster Market Growth Pune, India, April 25, 2022 (GLOBE NEWSWIRE) — The global blood glucose monitoring system market size is anticipated to rise during the forecast period due to the increasing prevalence of diabetes and technological development in medical equipment. Fortune Business Insights™ publishes this information in a report titled, “Blood Glucose Monitoring System Market, 2022-2029”. As per the report, the blood glucose monitoring system market size was USD 14.78 billion in 2021. The market size is expected to rise from USD 15.94 billion in 2022 to USD 31.34 billion by 2029 at a CAGR of...

Continue reading

CVW CleanTech Reports December 31, 2021 Year End Results

CALGARY, Alberta, April 25, 2022 (GLOBE NEWSWIRE) — CVW CleanTech Inc. (the “Company” or “CVW CleanTech”) (TSX-V: CVW) is pleased to announce its operating and financial results the three and twelve months period ended December 31, 2021. For complete details, please refer to the Financial Statements and associated Management Discussion and Analysis for the period ended December 31, 2021, available on SEDAR: (www.sedar.com) or on the Company’s website: www.CVWCleanTech.com. The Company also confirms that it will hold its Annual General Meeting as a virtual only meeting, online on Wednesday, June 22, 2022 at 11:00am local Calgary time. During 2021, CVW CleanTech and Canadian Natural Resources Limited (“Canadian Natural”) have focused on validation and optimization engineering at the Canadian Natural...

Continue reading

Sprott Asset Management Announces Acquisition of Assets Relating to the North Shore Global Uranium Mining ETF

URNM begins trading today as a series of Sprott Funds Trust, expanding the firm’s ETF offerings in that Trust TORONTO, April 25, 2022 (GLOBE NEWSWIRE) — Sprott Inc. (“Sprott”) (NYSE/TSX: SII) and Sprott Funds Trust jointly announced today that Sprott Asset Management LP (“Sprott Asset Management”), a wholly-owned subsidiary of Sprott, has completed the acquisition of certain assets relating to managing the North Shore Global Uranium Mining ETF (“URNM”), to which Exchange Traded Concepts, LLC acted as the investment adviser. Sprott Funds Trust and Exchange Traded Concepts Trust have completed the reorganization of the North Shore Global Uranium Mining ETF from a series of Exchange Traded Concepts Trust to Sprott Uranium Miners ETF, a series of Sprott Funds Trust. URNM is now advised by Sprott Asset Management and sub-advised...

Continue reading

Dorman Products, Inc. Reports First Quarter 2022 Results

Highlights:Record net sales of $401.6 million, up 39% year-over-year. Diluted earnings per share (“EPS”) of $1.11, up 9% compared to $1.02 in Q1 2021. Adjusted diluted EPS* of $1.29, up 24% compared to $1.04 in Q1 2021. The Company is reaffirming its fiscal 2022 guidance of net sales growth of 19% to 22%, diluted EPS of $4.94 to $5.14, and adjusted diluted EPS* of $5.35 to $5.55.COLMAR, Pa., April 25, 2022 (GLOBE NEWSWIRE) — Dorman Products, Inc. (the “Company” or “Dorman”) (NASDAQ:DORM), a leading supplier in the automotive aftermarket industry, today announced its financial results for the first quarter ended March 26, 2022. First Quarter Financial ResultsThe Company reported first quarter 2022 net sales of $401.6 million, up 39% compared to net sales of $288.0 million in the first quarter of 2021. The record first quarter...

Continue reading

Capital City Bank Group Reports First Quarter 2022 Results

TALLAHASSEE, Fla., April 25, 2022 (GLOBE NEWSWIRE) — Capital City Bank Group, Inc. (NASDAQ: CCBG) today reported net income attributable to common shareowners of $8.5 million, or $0.50 per diluted share, for the first quarter of 2022 compared to net income of $6.4 million, or $0.38 per diluted share, for the fourth quarter of 2021, and $9.5 million, or $0.56 per diluted share, for the first quarter of 2021. First Quarter 2022 HIGHLIGHTSPeriod-end loan balances grew $54 million, or 2.8% sequentially Net interest income gained momentum driven by growth in investment portfolio and higher rates Noninterest income increased by 4.6% sequentially, driven by wealth management fees (insurance commission revenues) Noninterest expense decreased $1.0 million, or 2.4% sequentially, attributable to lower pension plan expense Continued strong...

Continue reading

Update on offer for subscription

Octopus Apollo VCT plc Update on offer for subscription The Board of Octopus Apollo VCT plc (the “Company“) announced on 30 September 2021 that the Company had published a prospectus (the “Prospectus“) in connection with proposals to raise up to £40,000,000 (with an over-allotment facility to raise up to a further £35,000,000), by way of an offer for subscription (the “Offer“) of new ordinary shares (the “New Shares“). Full details of the Offer are contained in the Prospectus. The Company announced on 26 October 2021 that the Offer was closed to further applications and that the Company reserved the right to re-open the Offer to further applications. The Company has continued to identify and make new investments and, having considered the current rate of investment activity, the Board is...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.